Eli Lilly cuts cash prices for Zepbound weight-loss vials on LillyDirect, offering doses from $299 to $449 as demand for ...

Eli Lilly and Company LLY is one of the two companies that dominate the booming cardiometabolic space, driven by its successful GLP-1 therapies — Mounjaro for diabetes and Zepbound for weight loss, ...

ReBoost Nasal Spray has been recalled nationwide after tests found mold and bacteria, prompting FDA warnings of possible ...

These habitual market beaters can pull it off again.

Tirzepatide, used in Mounjaro and Zepbound, can produce dramatic weight loss and improvements in blood pressure, cholesterol ...

Under the partnership, Lilly will pay IU up to $40 million to build clinical trial infrastructure, accelerate access to ...

The company said some patients had dropped out of the trial because they felt they were losing too much weight.

USA: Researchers have found in a new study that stopping tirzepatide (Zepbound) often leads to weight regain, along with the ...

Citi Annual Global Healthcare Conference 2025 December 2, 2025 10:30 AM ESTCompany ParticipantsIlya Yuffa - Executive VP ...

They’re definitely easier and more affordable than injectables, but do they work as well? Here’s what you need to know.

The success of semaglutide and tirzepatide is evident in their 2024 sales volumes and revenues, creating a clearer picture of ...

Jennifer Stojkovic is pumped for Thanksgiving. As a new mom, she needs extra calories for recovery and breastfeeding — and the Super Bowl of Eating is the perfect excuse to load up. Stojkovic, who ...